Meeting NewsPerspective

Durvalumab reduces local, distant progression in non-small cell lung cancer

September 19, 2019
Durvalumab extended the time to first progression and reduced the risk for local and distant progression among patients with unresectable stage III…
Feature

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

September 18, 2019
The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular…
Meeting News

Induction radiation therapy before CAR-T reduces treatment-related toxicities

September 17, 2019
Patients who received radiation therapy before chimeric antigen receptor T-cell therapy for relapsed or refractory non-Hodgkin lymphoma were less…
Meeting News

FDA announces international collaboration, approves pembrolizumab plus lenvatinib for endometrial cancer

September 17, 2019
The FDA, in conjunction with decisions by regulatory agencies in Australia and Canada, granted accelerated approval to pembrolizumab in combination…
Meeting NewsPerspective

Radiation improves outcomes with pembrolizumab for metastatic lung cancer

September 17, 2019
The addition of stereotactic body radiotherapy after progression on pembrolizumab prolonged PFS among patients with metastatic non-small cell lung…

Combination prolongs PFS in relapsed or refractory myeloma

September 16, 2019
The addition of daratumumab to carfilzomib and dexamethasone extended PFS for patients with relapsed or refractory multiple myeloma, according to…
Trend Watch

Penn, Novartis end groundbreaking CAR-T relationship with new, more focused collaboration

September 16, 2019
The 7-year research and development alliance between Novartis and the University of Pennsylvania has concluded, with both organizations entering into…
Feature

CAR T-cell therapy has some patients crowdfunding to cover costs

September 13, 2019
Aletta Weiss plans to undergo chimeric antigen receptor T-cell treatment for relapsed large B-cell lymphoma, and she’s turning to GoFundMe for…

Atezolizumab extends OS for certain patients with non-small cell lung cancer

September 12, 2019
Atezolizumab as first-line monotherapy prolonged OS compared with chemotherapy alone for certain patients with non-small cell lung cancer, according…

Ohio State cancer center appoints hematology division director

September 12, 2019
Yiping Yang, MD, PhD, has been appointed director of the division of hematology at The Ohio State University Comprehensive Cancer Center —…